Clinical Trial Update: Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875) [Phase 2]

View source ↗

Summary

Phase 2 study P04875 reports efficacy and safety data for VICRIVIROC in HIV-infected treatment-naïve adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Vicriviroc (MK-7690)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections | Phase 2 | Status: COMPLETED